| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8714269 | The Journal of Allergy and Clinical Immunology: In Practice | 2018 | 8 Pages |
Abstract
We demonstrated that low PEF variability over 1 week, high serum IL-10 level, and low serum IL-33 concentration were useful factors for predicting that an adult's asthma will remain in control for months to years after a 50% reduction in the daily ICS dose.
Keywords
PEFIL-10ICSPC20IL-33SABAFeNOTSLPAdult asthmaAChLong-acting β2-agonistShort-acting β2-agonistfractional exhaled nitric oxideInnate immunityPeak expiratory flowRegulatory T cellLABAGlobal Initiative for AsthmaThymic stromal lymphopoietinAsthma managementHisthistamine dihydrochlorideAirway hyperresponsivenessInhaled corticosteroidStep-downGINA
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Naomi MD, Chiyako MD, Toshio MD, Goro MD, Masami MD, Takahiro MD, Shunsuke MD, Hiroshi PhD, Terufumi MD,